Estados financieros detallados de Genenta Science S.p.A. (GNTA): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $0.74, GNTA presenta beneficios negativos (P/E no significativo) y un ROE del -36.82%. La capitalización bursátil es de $14M.
Cuenta de Resultados (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | 0 | $1768 | $5096 | $5996 | $41705 | $46508 | $26973 |
| Beneficio Bruto | 0 | -$1768 | -$5096 | -$5996 | -$41705 | -$46508 | -$26973 |
| I+D | $3.7M | $4.4M | $3.5M | $5.2M | $6.4M | $5.0M | $2.6M |
| Generales y Administrativos | $908432 | $837353 | $2.4M | $5.6M | $5.1M | $5.1M | $3.7M |
| Gastos Operativos | $4.6M | $5.2M | $5.9M | $10.8M | $11.5M | $10.2M | $6.3M |
| Beneficio Operativo | -$4.6M | -$5.2M | -$5.9M | -$10.8M | -$11.5M | -$10.2M | -$6.3M |
| EBITDA | -$4.6M | -$5.2M | -$5.8M | -$8.3M | -$11.4M | -$9.3M | -$5.9M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | $384212 |
| Beneficio Antes de Impuestos | -$4.5M | -$5.2M | -$5.8M | -$8.3M | -$11.4M | -$9.3M | -$6.3M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$4.5M | -$5.2M | -$5.8M | -$8.3M | -$11.4M | -$9.3M | -$6.3M |
| BPA | $-0.25 | $-0.31 | $-0.31 | $-0.47 | $-0.64 | $-0.49 | $-0.33 |
| BPA Diluido | $-0.25 | $-0.31 | $-0.31 | $-0.47 | $-0.64 | $-0.49 | $-0.33 |
| Acciones en Circulación (Diluidas) | $18.1M | $18.1M | $18.2M | $18.2M | $18.2M | $18.3M | $19.7M |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $20.1M | $15.5M | $37.2M | $29.8M | $3.7M | $4.6M | $5.5M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | $15.1M | $8.1M | $22.6M |
| Cuentas por Cobrar | 0 | 0 | $1.4M | $1.6M | $2.0M | $1.4M | $1.3M |
| Inventario | -$163491 | $27671 | $76256 | $144689 | 0 | 0 | 0 |
| Activos Corrientes | $20.6M | $16.5M | $38.8M | $31.7M | $21.3M | $14.5M | $30.0M |
| Inmovilizado Material | 0 | $18971 | $23090 | $111639 | $57033 | $42922 | $22465 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | $88 | $53144 | $87800 | 0 |
| Activos Totales | $21.3M | $17.5M | $40.0M | $33.4M | $22.3M | $14.8M | $31.9M |
| Cuentas por Pagar | $572440 | $555015 | $189866 | $1.2M | $294975 | $317830 | $1.5M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $2.5M | $2.3M | $1.1M | $2.2M | $1.7M | $2.1M | $2.1M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | $7.6M |
| Pasivos Totales | $2.5M | $2.4M | $1.2M | $2.3M | $1.9M | $2.3M | $10.0M |
| Reservas | -$15.9M | -$21.5M | -$27.0M | -$35.5M | -$47.1M | -$56.1M | -$62.6M |
| Patrimonio Neto | $18.9M | $15.2M | $38.9M | $31.1M | $20.4M | $12.5M | $21.8M |
| Deuda Total | 0 | 0 | 0 | 0 | 0 | $14600 | $7.6M |
| Deuda Neta | -$20.1M | -$15.5M | -$37.2M | -$29.8M | -$18.8M | -$12.6M | -$20.5M |
| Capital Circulante | $18.1M | $14.2M | $37.6M | $29.5M | $19.5M | $12.4M | $27.9M |
Flujo de Caja (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$4.6M | -$5.6M | -$5.5M | -$8.5M | -$11.6M | -$8.9M | -$6.5M |
| Amortizaciones | 0 | $1900 | $4889 | $6140 | $42453 | $44523 | $28082 |
| Compensación en Acciones | $749512 | $460194 | $497104 | $722735 | $739884 | $847255 | $1.0M |
| Cambio en Capital Circulante | $1.4M | -$920717 | -$1.9M | $240297 | -$417597 | $1.7M | -$1.6M |
| Flujo de Caja Operativo | -$2.5M | -$6.0M | -$7.0M | -$7.4M | -$11.2M | -$6.2M | -$6.9M |
| Inversiones (CapEx) | 0 | -$20871 | -$9009 | -$27070 | -$13791 | -$4468 | -$7625 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$2.5M | -$6.1M | -$7.0M | -$7.4M | -$11.2M | -$6.2M | -$6.9M |
Crecimiento y Márgenes (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Crecimiento Beneficio Neto (anual) | -14.8% | -10.8% | -43.6% | -38.2% | +18.6% | +32.6% | |
| Crecimiento BPA (anual) | -24.0% | +0.0% | -51.6% | -36.2% | +23.4% | +32.7% | |
| Cambio en Acciones (anual) | +0.0% | +0.5% | +0.0% | +0.0% | +0.3% | +7.9% | |
| Crecimiento FCF (anual) | -143.6% | -14.9% | -6.9% | -50.7% | +44.3% | -10.1% | |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| FCF por Acción | $-0.14 | $-0.33 | $-0.38 | $-0.41 | $-0.62 | $-0.34 | $-0.35 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $18.1M | $18.1M | $18.2M | $18.2M | $18.2M | $18.3M | $19.7M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -36.82% |
| Rentabilidad sobre capital invertido | -21.33% |
| Rentabilidad sobre activos | -19.60% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.35 |
| Ratio corriente | 14.16 |
Ratios Clave (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| P/E | -39.23 | -29.03 | -31.09 | -10.93 | -7.00 | -8.57 | -3.84 |
| P/VC | 9.43 | 10.76 | 4.52 | 3.00 | 3.99 | 6.14 | 1.14 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Empresas relacionadas: BRNS · CVM · INMB · IPSC · JUNS · MDCX · MRSN
Explorar sector: Healthcare · Biotechnology
Más secciones de GNTA: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones